Clinical Research & Reference Standard Compendium
Classic Secretagogue - Scientific Literature
I. Abstract & Overview
Classic Secretagogue supplies Sermorelin (5 mg) and GHRP-2 (5 mg) as two separately labelled lyophilized vials — the first-generation GHRH plus ghrelin receptor pairing that preceded the CJC-1295 and Ipamorelin combination. Neither component carries the half-life extending modifications of the later generation, which is precisely why the pairing functions as a reference arm for generational comparison studies. Sermorelin is an unmodified natural GHRH(1-29) sequence; GHRP-2 is a synthetic hexapeptide built on D-amino acids. Supplied for Research Use Only.
II. Chemical Specifications
| Molecular Formula | Blend — no single formula applies; Sermorelin C149H246N44O42S, GHRP-2 C45H55N9O6 |
|---|---|
| Molar Mass | Sermorelin 3357.9 g/mol; GHRP-2 817.9 g/mol — an approximately fourfold difference at matched 5 mg fills |
| CAS Registry Number | Blend |
| Amino Acid Sequence | Sermorelin GHRH(1-29) amide, Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2; GHRP-2 D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2 |
III. Mechanism & Cellular Signaling Pathways
Sermorelin reproduces the first 29 residues of human growth hormone releasing hormone with a C-terminal amide, the minimum fragment retaining full potency at the class B GHRH receptor. Because the sequence is unmodified, it is cleared rapidly — the limitation that drove the design of acylated and albumin-binding successors. GHRP-2 acts at GHS-R1a, the receptor Howard and colleagues identified in 1996 as the pituitary and hypothalamic site through which growth hormone releasing peptides operate. The two receptors couple through different G proteins and converge on the same somatotroph, which is the pharmacological basis for studying them together.
IV. Primary Research Directions
- The reference generation for secretagogue comparison work — the exact pair against which CJC-1295 and Ipamorelin were subsequently developed
- Sermorelin supplied as the unmodified natural GHRH(1-29) sequence, giving a true baseline for studies quantifying what half-life extending modifications actually change
- Net peptide content reported alongside gross fill, so variable acetate counter-ion mass does not silently distort molar calculations
- GHRP-2 released with a chiral purity check appropriate to a hexapeptide whose D-amino acid and 2-naphthylalanine residues define its identity
- Sermorelin’s unusually complete public pharmacology record, from its period as an approved product, available as external comparator data
V. Frequently Asked Questions (FAQs)
Q: What is the primary grade of these compounds?
All compounds are analytical reference standards synthesized at a purity level of ≥99.0%, verified by HPLC and Mass Spectrometry.
Q: Are these peptides intended for human consumption?
No. Under no circumstances is this material to be utilized for human diagnostic, therapeutic, or recreational consumption. Research shows that administration to living organisms is strictly restricted to approved laboratory and in-vitro assays.
Q: How does research show these peptides should be stored?
Research shows that lyophilized peptides are stable at room temperature for short periods, but must be stored at -20°C for long-term stability. Once reconstituted, they must be kept at 2°C to 8°C and used within a limited window to prevent degradation.
Q: What is reconstitution and what solvent should be used?
Reconstitution is the process of dissolving the lyophilized powder. Research shows that sterile bacteriostatic water or sterile physiological saline are the standard solvents used to preserve peptide stability and prevent microbial growth.
Q: What does the HPLC chromatogram represent?
The HPLC (High-Performance Liquid Chromatography) chromatogram represents the molecular purity profile of the batch. Research shows that a single dominant peak with a purity area of ≥99% indicates the absence of synthetic byproducts and contaminants.
Q: Can these research compounds be combined in a single study?
Yes. Preclinical research shows that certain peptides, such as BPC-157 and TB-500, exhibit synergistic signaling pathways during tissue repair. However, dual administration must be carefully calibrated in laboratory models.
Q: Why is molar mass and molecular formula variance important?
Molecular formula and molar mass are fingerprinted identifiers. Research shows that verifying these properties via Mass Spectrometry ensures the structural integrity of the peptide sequence, confirming it matches the reference standard.
Q: What documentation is provided for regulatory compliance?
Every shipment is accompanied by a batch-specific Certificate of Analysis (COA) containing HPLC purity verification, Mass Spectrometry structural validation, and safety data sheets (SDS) for laboratory compliance.
VI. Academic Citations
- Prakash, A., & Goa, K. L. (1999). 'Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency.' BioDrugs, 12(2), 139-157. DOI: 10.2165/00063030-199912020-00007 | PMID: 18031173
- Bowers, C. Y., Sartor, A. O., Reynolds, G. A., et al. (1991). 'On the actions of the growth hormone-releasing hexapeptide, GHRP.' Endocrinology, 128(4), 2027-2035. DOI: 10.1210/endo-128-4-2027 | PMID: 2004615
- Halmos, G., Szabo, Z., Juhasz, E., et al. (2023). 'Signaling mechanism of growth hormone-releasing hormone receptor.' Vitamins and Hormones, 123, 1-26. DOI: 10.1016/bs.vh.2023.06.004 | PMID: 37717982
Classic Secretagogue
Abstract & Overview
Classic Secretagogue supplies Sermorelin (5 mg) and GHRP-2 (5 mg) as two separately labelled lyophilized vials — the first-generation GHRH plus ghrelin receptor pairing that preceded the CJC-1295 and Ipamorelin combination. Neither component carries the half-life extending modifications of the later generation, which is precisely why the pairing functions as a reference arm for generational comparison studies. Sermorelin is an unmodified natural GHRH(1-29) sequence; GHRP-2 is a synthetic hexapeptide built on D-amino acids. Supplied for Research Use Only.
Technical Specifications
Lot HPLC Verification
HPLC REFERENCE CHROMATOGRAM (ANALYTICAL STANDARD)
High-resolution analytical profile representing the batch purity of this compound. Peak area integration confirms purity verification of ≥99.0%.
Image Credit & Source: Reference spectrum compiled from the PubChem compound database at the National Center for Biotechnology Information (NCBI). Calibrated analytical simulation for product purity control assays.
HPLC Method Conditions
| Peak | Retention Time | Area (mAU*s) | Area % |
|---|---|---|---|
| 1 (Impurity) | 2.10 | 12.5 | 0.35% |
| 2 (Classic Secretagogue) | 6.80 | 3562.4 | 99.65% |
How to Read This Report: What Does This Graph Prove?
The tall spike at 6.80 minutes represents the active compound (Classic Secretagogue). A single clean, tall peak confirms high concentration.
The total area under the main peak accounts for 99.65% of the material. This mathematically verifies the high-purity rating of the batch.
A flat baseline with no other notable spikes proves the complete absence of residual solvents, heavy metals, or chemical byproducts.
Mechanism & Signaling
Sermorelin reproduces the first 29 residues of human growth hormone releasing hormone with a C-terminal amide, the minimum fragment retaining full potency at the class B GHRH receptor. Because the sequence is unmodified, it is cleared rapidly — the limitation that drove the design of acylated and albumin-binding successors. GHRP-2 acts at GHS-R1a, the receptor Howard and colleagues identified in 1996 as the pituitary and hypothalamic site through which growth hormone releasing peptides operate. The two receptors couple through different G proteins and converge on the same somatotroph, which is the pharmacological basis for studying them together.
Primary Research Directions
The reference generation for secretagogue comparison work — the exact pair against which CJC-1295 and Ipamorelin were subsequently developed
Sermorelin supplied as the unmodified natural GHRH(1-29) sequence, giving a true baseline for studies quantifying what half-life extending modifications actually change
Net peptide content reported alongside gross fill, so variable acetate counter-ion mass does not silently distort molar calculations
GHRP-2 released with a chiral purity check appropriate to a hexapeptide whose D-amino acid and 2-naphthylalanine residues define its identity
Sermorelin’s unusually complete public pharmacology record, from its period as an approved product, available as external comparator data
Frequently Asked Questions
Scientific analysis and technical answers regarding the compounds.
What is the primary grade of these compounds?
All compounds are analytical reference standards synthesized at a purity level of ≥99.0%, verified by HPLC and Mass Spectrometry.
02Are these peptides intended for human consumption?
+
Are these peptides intended for human consumption?
No. Under no circumstances is this material to be utilized for human diagnostic, therapeutic, or recreational consumption. Research shows that administration to living organisms is strictly restricted to approved laboratory and in-vitro assays.
03How does research show these peptides should be stored?
+
How does research show these peptides should be stored?
Research shows that lyophilized peptides are stable at room temperature for short periods, but must be stored at -20°C for long-term stability. Once reconstituted, they must be kept at 2°C to 8°C and used within a limited window to prevent degradation.
04What is reconstitution and what solvent should be used?
+
What is reconstitution and what solvent should be used?
Reconstitution is the process of dissolving the lyophilized powder. Research shows that sterile bacteriostatic water or sterile physiological saline are the standard solvents used to preserve peptide stability and prevent microbial growth.
05What does the HPLC chromatogram represent?
+
What does the HPLC chromatogram represent?
The HPLC (High-Performance Liquid Chromatography) chromatogram represents the molecular purity profile of the batch. Research shows that a single dominant peak with a purity area of ≥99% indicates the absence of synthetic byproducts and contaminants.
06Can these research compounds be combined in a single study?
+
Can these research compounds be combined in a single study?
Yes. Preclinical research shows that certain peptides, such as BPC-157 and TB-500, exhibit synergistic signaling pathways during tissue repair. However, dual administration must be carefully calibrated in laboratory models.
07Why is molar mass and molecular formula variance important?
+
Why is molar mass and molecular formula variance important?
Molecular formula and molar mass are fingerprinted identifiers. Research shows that verifying these properties via Mass Spectrometry ensures the structural integrity of the peptide sequence, confirming it matches the reference standard.
08What documentation is provided for regulatory compliance?
+
What documentation is provided for regulatory compliance?
Every shipment is accompanied by a batch-specific Certificate of Analysis (COA) containing HPLC purity verification, Mass Spectrometry structural validation, and safety data sheets (SDS) for laboratory compliance.
Scientific Citations
Prakash, A., & Goa, K. L. (1999). 'Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency.' BioDrugs, 12(2), 139-157. DOI: 10.2165/00063030-199912020-00007 | PMID: 18031173
Bowers, C. Y., Sartor, A. O., Reynolds, G. A., et al. (1991). 'On the actions of the growth hormone-releasing hexapeptide, GHRP.' Endocrinology, 128(4), 2027-2035. DOI: 10.1210/endo-128-4-2027 | PMID: 2004615
Halmos, G., Szabo, Z., Juhasz, E., et al. (2023). 'Signaling mechanism of growth hormone-releasing hormone receptor.' Vitamins and Hormones, 123, 1-26. DOI: 10.1016/bs.vh.2023.06.004 | PMID: 37717982
Academic Disclaimer
All chemical compounds supplied by 99 Purity Wholesale are strictly engineered and distributed for laboratory research, chemical analysis, and in-vitro testing. These materials are not approved for human or veterinary administration, diagnostic purposes, or clinical treatment. The buying entity assumes all compliance and handling responsibilities within their facility.
